Today's special offer: Access for Free!!!

Profile
Financial Statement
- Income Statement
- Comprehensive Income
- Assets
- Liabilities and Stockholders' Equity
- Statement of Cash Flows
Common-Size
- Income Statement
- Assets
- Liabilities and Stockholders' Equity
Ratios
- Short-term Activity
- Long-term Activity
- Liquidity
- Long-term Debt and Solvency
- Profitability
- DuPont
Relative Valuation
- Ratios (Price Multiples)
- Enterprise Value (EV)
- EV to EBITDA
- EV to FCFF
- Price to FCFE
DCF
- CAPM
- DDM
- Present Value of FCFF
- Present Value of FCFE
Analysis
- Revenues
- Investments
- Inventory
- Property, Plant and Equipment
- Goodwill and Intangible Assets
- Debt
- Income Taxes
Reporting Quality
- Aggregate Accruals

Pfizer Inc. (PFE) | Common-Size Income Statement

See also

Johnson & Johnson (JNJ), Common-Size Income Statement
Novartis AG (NVS), Common-Size Income Statement
Merck & Co. Inc. (MRK), Common-Size Income Statement
GlaxoSmithKline PLC (GSK), Common-Size Income Statement
Abbott Laboratories (ABT), Common-Size Income Statement
Sanofi (SNY), Common-Size Income Statement
Novo Nordisk A/S (NVO), Common-Size Income Statement
UnitedHealth Group Inc. (UNH), Common-Size Income Statement
Bristol-Myers Squibb Co. (BMY), Common-Size Income Statement
AstraZeneca PLC (AZN), Common-Size Income Statement
Eli Lilly & Co. (LLY), Common-Size Income Statement
Medtronic Inc. (MDT), Common-Size Income Statement
Baxter International Inc. (BAX), Common-Size Income Statement

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Pfizer Inc., Common-Size Consolidated Income Statement

Export to Excel

Export to OpenOffice.org

		Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
	Revenues
	Cost of sales
	Gross profit	%	%	%	%	%
	Selling, informational and administrative expenses
	Research and development expenses
	Amortization of intangible assets
	Acquisition-related in-process research and development charges
	Restructuring charges and certain acquisition-related costs
	Royalty-related income
	Net gain (loss) on asset disposals
	Certain legal matters, net
	Certain asset impairment charges
	Gain related to ViiV
	Other, net
	Other income (expense), net	%	%	%	%	%
	Operating income	%	%	%	%	%
	Interest income
	Interest expense
	Net interest income (expense)	%	%	%	%	%
	Income from continuing operations before provision for taxes on income	%	%	%	%	%
	Provision for taxes on income
	Income from continuing operations	%	%	%	%	%
	Discontinued operations, net of tax
	Net income before allocation to noncontrolling interests	%	%	%	%	%
	Net income attributable to noncontrolling interests
	Net income attributable to Pfizer Inc.	%	%	%	%	%

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center